Assessing the effectiveness of fluorinated and α-methylated 3-boronophenylalanine for improved tumor-specific boron delivery in boron neutron capture therapy

Barth, 2005, Boron neutron capture therapy of cancer: current status and future prospects, Clin Cancer Res, 11, 3987, 10.1158/1078-0432.CCR-05-0035 Nedunchezhian, 2016, Boron neutron capture therapy - A literature review, J Clin Diagn Res, 10, ZE01 Wongthai, 2015, Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2, Cancer Sci, 106, 279, 10.1111/cas.12602 Kanno, 2021, Designation products: boron neutron capture therapy for head and neck carcinoma, Oncologist, 26, e1250, 10.1002/onco.13805 Ailuno, 2022, Boron vehiculating nanosystems for neutron capture therapy in cancer treatment, Cells, 11, 4029, 10.3390/cells11244029 Watanabe, 2023, Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy, J Radiat Res, 64, 91, 10.1093/jrr/rrac077 Fukuda, 2020, Pharmacokinetics of 10B-p-boronophenylalanine (BPA) in the blood and tumors in human patients: A critical review with special reference to tumor-to-blood (T/B) ratios using resected tumor samples, Appl Radiat Isot, 166, 10.1016/j.apradiso.2020.109308 Coghi, 2023, Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment, Med Res Rev, 43, 1809, 10.1002/med.21964 Cheng, 2022, Boron neutron capture therapy: Clinical application and research progress, Curr Oncol, 29, 7868, 10.3390/curroncol29100622 Wang, 2019, Synthesis and initial biological evaluation of boron-containing prostate-specific membrane antigen ligands for treatment of prostate cancer using boron neutron capture therapy, Mol Pharm, 16, 3831, 10.1021/acs.molpharmaceut.9b00464 Miyabe, 2019, Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter, J Pharmacol Sci, 139, 215, 10.1016/j.jphs.2019.01.012 Li, 2022, Boron encapsulated in a liposome can be used for combinational neutron capture therapy, Nat Commun, 13, 2143, 10.1038/s41467-022-29780-w Yanagie, 2021, Suppression of tumor growth in a rabbit hepatic cancer model by boron neutron capture therapy with liposomal boron delivery systems, In Vivo, 35, 3125, 10.21873/invivo.12607 Rondina, 2021, A boron delivery antibody (BDA) with boronated specific residues: new perspectives in boron neutron capture therapy from an in silico investigation, Cells, 10, 3225, 10.3390/cells10113225 Ali, 2020, Boron chemistry for medical applications, Molecules, 25, 828, 10.3390/molecules25040828 Hosmane, 2018, 4 Hey-Hawkins, 2018, Boron-based compounds: potential and emerging applications in medicine, WILEY Lin, 2020, Similar T/N ratio between 18F-FBPA diagnostic and BPA therapeutic dosages for boron neutron capture therapy in orthotropic tongue cancer model, Ann Nucl Med, 34, 58, 10.1007/s12149-019-01415-z Chen, 2021, Salvage boron neutron capture therapy for malignant brain tumor patients in compliance with emergency and compassionate use: Evaluation of 34 cases in taiwan, Biology (basel), 10, 334 Shah, 2007, The role of fluorine in medicinal chemistry, J Enzyme Inhib Med Chem, 22, 527, 10.1080/14756360701425014 Purser, 2008, Fluorine in medicinal chemistry, Chem Soc Rev, 37, 320, 10.1039/B610213C Watabe, 2017, 18F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with 18F-FDG and 11C-Methionine PET, Eur J Nucl Med Mol Imaging, 44, 321, 10.1007/s00259-016-3487-1 Ichikawa, 2021, meta-Non-flat substituents: a novel molecular design to improve aqueous solubility in small molecule drug discovery, Org Biomol Chem, 19, 446, 10.1039/D0OB02083D Kondo, 2022, Evaluation of 3-borono-L-phenylalanine as a water-soluble boron neutron capture therapy agent, Pharmaceutics, 14, 1106, 10.3390/pharmaceutics14051106 Khunweeraphong, 2012, Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties, J Pharmacol Sci, 119, 368, 10.1254/jphs.12124FP Wiriyasermkul, 2012, Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET, J Nucl Med, 53, 1253, 10.2967/jnumed.112.103069 Kitamura, 2005, Powerful chiral phase-transfer catalysts for the asymmetric synthesis of alpha-alkyl- and alpha, alpha-dialkyl-alpha-amino acids, Angew Chem Int Ed Engl, 44, 1549, 10.1002/anie.200462257 Ishikawa, 2011, Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry, J Med Chem, 54, 1539, 10.1021/jm101356p Stein, G.A., Bronner, H.A., and Pfister 3rd, K., α-Methyl α-amino acids. II. 1 Derivatives of DL-phenylalanine. J Am Chem Soc, 1955. 77(3): p. 700-703. Rooman, 2013, Amino acid transporters expression in acinar cells is changed during acute pancreatitis, Pancreatology, 13, 475, 10.1016/j.pan.2013.06.006 Takada, 2015, Whole-body dose evaluation with an adaptive treatment planning system for boron neutron capture therapy, Radiat Prot Dosimetry, 167, 584, 10.1093/rpd/ncu357 Jin, 2020, Interaction of halogenated tyrosine/phenylalanine derivatives with organic anion transporter 1 in the renal handling of tumor imaging probes, J Pharmacol Exp Ther, 375, 451, 10.1124/jpet.120.000235 Rossier, 1999, LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine, J Biol Chem, 274, 34948, 10.1074/jbc.274.49.34948 Hanaoka, 2015, Development of a widely usable amino acid tracer: 76Br-α-methyl-phenylalanine for tumor PET imaging, J Nucl Med, 56, 791, 10.2967/jnumed.114.152215 Wester, 1999, Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging, J Nucl Med, 40, 205 Ohshima, 2013, Biological evaluation of 3-[18F]fluoro-α-methyl-D-tyrosine (D-[18F]FAMT) as a novel amino acid tracer for positron emission tomography, Ann Nucl Med, 27, 314, 10.1007/s12149-013-0687-7 Yoshimoto, 2018, Non-invasive estimation of 10B-4-borono-L-phenylalanine-derived boron concentration in tumors by PET using 4-borono-2-18F-fluoro-phenylalanine, Cancer Sci, 109, 1617, 10.1111/cas.13553 Measures, 2016, Isoxazole-derived amino acids are bromodomain-binding acetyl-lysine mimics: Incorporation into histone H4 peptides and histone H3, Angew Chem Int Ed Engl, 55, 8353, 10.1002/anie.201602908